These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 25428648)

  • 21. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
    Berhanu A; Wilson RL; Kirkwood-Watts DL; King DS; Warren TK; Lund SA; Brown LL; Krupkin AK; Vandermay E; Weimers W; Honeychurch KM; Grosenbach DW; Jones KF; Hruby DE
    J Virol; 2008 Apr; 82(7):3517-29. PubMed ID: 18199639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The new ACAM2000 vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks.
    Handley L; Buller RM; Frey SE; Bellone C; Parker S
    Expert Rev Vaccines; 2009 Jul; 8(7):841-50. PubMed ID: 19538111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smallpox vaccination and patients with human immunodeficiency virus infection or acquired immunodeficiency syndrome.
    Bartlett JG
    Clin Infect Dis; 2003 Feb; 36(4):468-71. PubMed ID: 12567305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response to smallpox vaccine in persons immunized in the distant past.
    Frey SE; Newman FK; Yan L; Lottenbach KR; Belshe RB
    JAMA; 2003 Jun; 289(24):3295-9. PubMed ID: 12824212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse events associated with smallpox vaccination in the United States, January-October 2003.
    Casey CG; Iskander JK; Roper MH; Mast EE; Wen XJ; Török TJ; Chapman LE; Swerdlow DL; Morgan J; Heffelfinger JD; Vitek C; Reef SE; Hasbrouck LM; Damon I; Neff L; Vellozzi C; McCauley M; Strikas RA; Mootrey G
    JAMA; 2005 Dec; 294(21):2734-43. PubMed ID: 16333009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokine expression patterns associated with systemic adverse events following smallpox immunization.
    McKinney BA; Reif DM; Rock MT; Edwards KM; Kingsmore SF; Moore JH; Crowe JE
    J Infect Dis; 2006 Aug; 194(4):444-53. PubMed ID: 16845627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipients.
    Kennedy RB; Ovsyannikova IG; Pankratz VS; Haralambieva IH; Vierkant RA; Poland GA
    Hum Genet; 2012 Sep; 131(9):1403-21. PubMed ID: 22610502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detailed kinetics of immune responses to a new cell culture-derived smallpox vaccine in vaccinia-naïve adults.
    Kim SH; Choi SJ; Park WB; Kim HB; Kim NJ; Oh MD; Choe KW
    Vaccine; 2007 Aug; 25(33):6287-91. PubMed ID: 17597266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smallpox: a review of clinical disease and vaccination.
    Lofquist JM; Weimert NA; Hayney MS
    Am J Health Syst Pharm; 2003 Apr; 60(8):749-56; quiz 757-8. PubMed ID: 12749161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomised controlled trial.
    Greenberg RN; Kennedy JS; Clanton DJ; Plummer EA; Hague L; Cruz J; Ennis FA; Blackwelder WC; Hopkins RJ
    Lancet; 2005 Jan 29-Feb 4; 365(9457):398-409. PubMed ID: 15680454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of immunity to vaccinia virus by using diluted inactivated vaccinia vaccine solution for skin testing.
    Somekh E; Smetana Z; Tanay A; Dalal I; Babai I; Mendelson E
    Vaccine; 2004 Dec; 23(3):321-4. PubMed ID: 15530675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LC16m8: an attenuated smallpox vaccine.
    Kenner J; Cameron F; Empig C; Jobes DV; Gurwith M
    Vaccine; 2006 Nov; 24(47-48):7009-22. PubMed ID: 17052815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of modified vaccinia virus Ankara as an alternative vaccine against smallpox in chronically HIV type 1-infected individuals undergoing HAART.
    Cosma A; Nagaraj R; Staib C; Diemer C; Wopfner F; Schätzl H; Busch DH; Sutter G; Goebel FD; Erfle V
    AIDS Res Hum Retroviruses; 2007 Jun; 23(6):782-93. PubMed ID: 17604541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine: a randomized controlled trial.
    Talbot TR; Stapleton JT; Brady RC; Winokur PL; Bernstein DI; Germanson T; Yoder SM; Rock MT; Crowe JE; Edwards KM
    JAMA; 2004 Sep; 292(10):1205-12. PubMed ID: 15353533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-related effects of smallpox vaccine.
    Frey SE; Newman FK; Cruz J; Shelton WB; Tennant JM; Polach T; Rothman AL; Kennedy JS; Wolff M; Belshe RB; Ennis FA
    N Engl J Med; 2002 Apr; 346(17):1275-80. PubMed ID: 11923489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smallpox vaccine, ACAM2000: Sites and duration of viral shedding and effect of povidone iodine on scarification site shedding and immune response.
    Pittman PR; Garman PM; Kim SH; Schmader TJ; Nieding WJ; Pike JG; Knight R; Johnston SC; Huggins JW; Kortepeter MG; Korman L; Ranadive M; Quinn X; Meyers MS
    Vaccine; 2015 Jun; 33(26):2990-6. PubMed ID: 25930115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection.
    Coulibaly S; Brühl P; Mayrhofer J; Schmid K; Gerencer M; Falkner FG
    Virology; 2005 Oct; 341(1):91-101. PubMed ID: 16061267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smallpox vaccine: problems and prospects.
    Poland GA; Neff JM
    Immunol Allergy Clin North Am; 2003 Nov; 23(4):731-43. PubMed ID: 14753389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smallpox: clinical features, prevention, and management.
    Guharoy R; Panzik R; Noviasky JA; Krenzelok EP; Blair DC
    Ann Pharmacother; 2004 Mar; 38(3):440-7. PubMed ID: 14755066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myocarditis: the unexpected return of smallpox vaccine adverse events.
    Chen RT; Lane JM
    Lancet; 2003 Oct; 362(9393):1345-6. PubMed ID: 14585633
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.